Journal of Clinical Endocrinology & Metabolism, Vol 59, 1143-1147, Copyright © 1984 by Endocrine Society

ARTICLES

Etomidate suppresses adrenocortical function by inhibition of 11 beta- hydroxylation

FH de Jong, C Mallios, C Jansen, PA Scheck and SW Lamberts

We studied the effect of short term infusion of the imidazole-derived anesthetic agent etomidate on plasma concentrations of ACTH, cortisol, and the cortisol-precursors 11-desoxycortisol and 17- hydroxyprogesterone. During the infusion of etomidate, a significant increase in the peripheral concentration of ACTH occurred, while plasma cortisol concentrations decreased. After the end of the infusion, cortisol concentrations further decreased, while the concentrations of desoxycortisol and 17-hydroxyprogesterone increased. Furthermore, in in vitro experiments with isolated rat pituitary and adrenal cells, etomidate did not affect corticotropin-releasing hormone-induced ACTH secretion from pituitary cells, whereas ACTH-stimulated corticosterone secretion from adrenal cells was inhibited by addition of etomidate in concentrations which occur in plasma during and after infusion of the drug. These results lead to the conclusion that etomidate inhibits adrenal 11 beta-hydroxylation.

This article has been cited by other articles:

				J. M. Walz, M. Zayaruzny, and S. O. Heard Airway Management in Critical Illness Chest, February 1, 2007; 131(2): 608 - 620. [Abstract] [Full Text] [PDF]

				N. G M Beckers, P. Platteau, M. J Eijkemans, N. S Macklon, F. H de Jong, P. Devroey, and B. C J M Fauser The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur. J. Endocrinol., August 1, 2006; 155(2): 355 - 363. [Abstract] [Full Text] [PDF]

				A. Hagendorf, J. W. Koper, F. H. de Jong, A. O. Brinkmann, S. W. J. Lamberts, and R. A. Feelders Expression of the Human Glucocorticoid Receptor Splice Variants {alpha}, {beta}, and P in Peripheral Blood Mononuclear Leukocytes in Healthy Controls and in Patients with Hyper- and Hypocortisolism J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6237 - 6243. [Abstract] [Full Text] [PDF]

				M. den Brinker, K. F. M. Joosten, O. Liem, F. H. de Jong, W. C. J. Hop, J. A. Hazelzet, M. van Dijk, and A. C. S. Hokken-Koelega Adrenal Insufficiency in Meningococcal Sepsis: Bioavailable Cortisol Levels and Impact of Interleukin-6 Levels and Intubation with Etomidate on Adrenal Function and Mortality J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5110 - 5117. [Abstract] [Full Text] [PDF]

				W. L. Jackson Jr Should We Use Etomidate as an Induction Agent for Endotracheal Intubation in Patients With Septic Shock?: A Critical Appraisal Chest, March 1, 2005; 127(3): 1031 - 1038. [Abstract] [Full Text] [PDF]

				S. S. Magill, T. Puthanakit, S. M. Swoboda, K. A. Carson, R. Salvatori, P. A. Lipsett, and C. W. Hendrix Impact of Fluconazole Prophylaxis on Cortisol Levels in Critically Ill Surgical Patients Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2471 - 2476. [Abstract] [Full Text] [PDF]

				H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035. [Abstract] [Full Text]

				J. W. Newcomer, G. Selke, A. K. Melson, T. Hershey, S. Craft, K. Richards, and A. L. Alderson Decreased Memory Performance in Healthy Humans Induced by Stress-Level Cortisol Treatment Arch Gen Psychiatry, June 1, 1999; 56(6): 527 - 533. [Abstract] [Full Text] [PDF]

				S. W.J. Lamberts, H. A. Bruining, and F. H. de Jong Corticosteroid Therapy in Severe Illness N. Engl. J. Med., October 30, 1997; 337(18): 1285 - 1292. [Full Text] [PDF]

				P. D. Cooper Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 621 - 621. [Full Text]